수의 임상시험 시장 규모, 점유율, 동향 분석 보고서 : 동물별, 적응증별, 중재별, 스폰서별, 지역별, 부문별 예측(2024-2030년)

Veterinary Clinical Trials Market Growth & Trends:

The global veterinary clinical trials market size is expected to reach USD 8.99 billion by 2030, exhibiting a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving industry growth include increased R&D expenditure by key players, rising prevalence of chronic diseases in animals, advancements in veterinary medicines, and rise in strategic alliances. For instance, in April 2024, Boehringer Ingelheim, a biopharmaceutical company focused on both human and animal health invested USD 593.5 Mn in animal health R&D to accelerate veterinary clinical trials as well as to develop innovative veterinary medicine.

Additionally, an increasing number of clinical trials for rare diseases in pets is expected to drive veterinary clinical trial market. Veterinary clinics and research institutions are undertaking specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques designed for individual dogs' genetic profiles. For instance, in March 2024, Vivesto AB initiated its Paccal Vet clinical trial for dogs with splenic hemangiosarcoma, marking a significant step toward addressing this challenging cancer type in canines. The trial aims to assess the safety and efficacy of Paccal Vet, formulated with XR-17 technology, with promising results potentially leading to further pivotal studies.

There is a growing focus on preventive care in veterinary medicine. Clinical trials aimed at developing preventive treatments, such as vaccines and early diagnostic tools, are becoming more common. Furthermore, veterinary clinics and research institutions are launching specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques tailored to individual dogs' genetic profiles.

Veterinary Clinical Trials Market Report Highlights:

• Ongoing advancements in veterinary medicine drive the demand for veterinary clinical trials to improve animal health and welfare. Additionally, growing R&D investments by key players to innovate veterinary medicine are expected to boost market demand.
• By animal type,companion animal segment dominated the market in 2023 and is projected to witness the fastest growth rate of 9.5% in the coming years. Furthermore, among companion animals, canines segment is holding highest market share in 2023.
• In terms of indication, oncology segment dominated the market with a share of 27.51% in 2023, owing to the rising prevalence of cancers in animals and growing R&D investment for veterinary oncology. Whereas internal medicine segment is expected to grow at the fastest rate of over 10.2% in the coming years.
• Based on the sponsor, pharmaceutical and biopharmaceutical companies segment dominated the market in 2023, and the academics and research centers segment is expected to grow at the fastest rate of over 9.8% in the coming years.
• Medicines accounted for the largest market share by intervention type in 2023. However, medical device segment is estimated to witness the highest growth rate of around 10.0% in the near future.
• In 2023, North America held the highest share of 33.70% of the market by region. The Asia Pacific region is expected to grow at the fastest rate of over 10.1% in the coming years.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates And Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis
  • 1.6.2. Global Market: CAGR Calculation
• 1.7. Research Scope and Assumptions
  • 1.7.1. List of Secondary Sources
  • 1.7.2. List of Primary Sources
  • 1.7.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Clinical Trials Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Increasing Pet Population & Expenditure
    • 3.2.1.2. Rising Prevalence Of Chronic Diseases in Animals
    • 3.2.1.3. Growing Advancement In Technology
    • 3.2.1.4. Increase in RD Expenditure
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Stringent Regulatory Requirements
    • 3.2.2.2. High Cost of Clinical Trials
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Veterinary Clinical Trials Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal landscape
• 3.4. Covid-19 Analysis
• 3.5. Estimated Pet Population, by key countries

Chapter 4. Veterinary Clinical Trials Market: Animal Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Veterinary Clinical Trials Market Movement Analysis
• 4.3. Global Veterinary Clinical Trials Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
• 4.4. Companion Animal
  • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Canine
    • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Feline
    • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Equine
    • 4.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Livestock Animal
  • 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Other animals
  • 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Clinical Trials Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Veterinary Clinical Trials Market Movement Analysis
• 5.3. Global Veterinary Clinical Trials Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 5.4. Oncology
  • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Internal medicine
  • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Orthopedics
  • 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Cardiology
  • 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.8. Neurology
  • 5.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.9. Ophthalmology
  • 5.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.10. Dermatology
  • 5.10.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.11. Others Indication
  • 5.11.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Clinical Trials Market: Intervention Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Veterinary Clinical Trials Market Movement Analysis
• 6.3. Global Veterinary Clinical Trials Market Size & Trend Analysis, by Intervention, 2018 to 2030 (USD Million)
• 6.4. Medicines
  • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Medical Device
  • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Clinical Trials Market: Sponsor Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Veterinary Clinical Trials Market Movement Analysis
• 7.3. Global Veterinary Clinical Trials Market Size & Trend Analysis, Sponsor, 2018 to 2030 (USD Million)
• 7.4. Pharmaceutical and Biopharmaceutical companies
  • 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Academics and Research centers
  • 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Clinical Trials Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 North America
• 8.3. North America
  • 8.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Insights
    • 8.3.2.3. U.S. Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Insights
    • 8.3.3.3. Canada Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Insights
    • 8.3.4.3. Mexico Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.K.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Insights
    • 8.4.2.3. U.K. Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Insights
    • 8.4.3.3. Germany Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Insights
    • 8.4.4.3. France Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Insights
    • 8.4.5.3. Italy Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Insights
    • 8.4.6.3. Spain Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Insights
    • 8.4.7.3. Sweden Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Insights
    • 8.4.8.3. Denmark Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Insights
    • 8.4.9.3. Norway Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Insights
    • 8.5.2.3. China Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Japan
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Insights
    • 8.5.3.3. Japan Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Insights
    • 8.5.4.3. India Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Insights
    • 8.5.5.3. South Korea Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Insights
    • 8.5.6.3. Australia Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Insights
    • 8.5.7.3. Thailand Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Insights
    • 8.6.2.3. Brazil Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Insights
    • 8.6.3.3. Argentina Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Middle East and Africa
  • 8.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Insights
    • 8.7.2.3. Saudi Arabia Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. South Africa
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Insights
    • 8.7.3.3. South Africa Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Insights
    • 8.7.4.3. UAE Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Insights
    • 8.7.5.3. Kuwait Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heat Map Analysis
• 9.3. Estimated Company Market Share Analysis, 2023
• 9.4. Strategy Mapping
  • 9.4.1. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Others
• 9.5. Company Profiles
  • 9.5.1. Charles River Laboratory
    • 9.5.1.1. Participant's Overview
    • 9.5.1.2. Financial Performance
    • 9.5.1.3. Product Benchmarking
    • 9.5.1.4. Strategic Initiatives
  • 9.5.2. IDEXX Laboratories, Inc.
    • 9.5.2.1. Participant's Overview
    • 9.5.2.2. Financial Performance
    • 9.5.2.3. Product Benchmarking
    • 9.5.2.4. Strategic Initiatives
  • 9.5.3. Cebiphar.
    • 9.5.3.1. Participant's Overview
    • 9.5.3.2. Financial Performance
    • 9.5.3.3. Product Benchmarking
    • 9.5.3.4. Strategic Initiatives
  • 9.5.4. Argenta.
    • 9.5.4.1. Participant's Overview
    • 9.5.4.2. Financial Performance
    • 9.5.4.3. Product Benchmarking
    • 9.5.4.4. Strategic Initiatives
  • 9.5.5. Bioagile Therapeutics Pvt. Ltd.
    • 9.5.5.1. Participant's Overview
    • 9.5.5.2. Financial Performance
    • 9.5.5.3. Product Benchmarking
    • 9.5.5.4. Strategic Initiatives
  • 9.5.6. Veterinary Research Management.
    • 9.5.6.1. Participant's Overview
    • 9.5.6.2. Financial Performance
    • 9.5.6.3. Product Benchmarking
    • 9.5.6.4. Strategic Initiatives
  • 9.5.7. Clinvet.
    • 9.5.7.1. Participant's Overview
    • 9.5.7.2. Financial Performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic Initiatives
  • 9.5.8. Labcorp Drug Development.
    • 9.5.8.1. Participant's Overview
    • 9.5.8.2. Financial Performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic Initiatives
  • 9.5.9. OCR - Oncovet Clinical Research.
    • 9.5.9.1. Participant's Overview
    • 9.5.9.2. Financial Performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic Initiatives
  • 9.5.10. Vivesto AB.
    • 9.5.10.1. Participant's Overview
    • 9.5.10.2. Financial Performance
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Strategic Initiatives

Chapter 10. Key Takeaways